On the other hand, the cumulative risk of colorectal cancer and endometrial cancer in carriers of a concurrent deletion of the EPCAM and MSH2 genes is reported to be similar to that in MSH2 variant carriers10. Here, MSH2 is linked to endometrial cancer.